Probiotics for Bipolar Disorder

Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Sheppard Pratt Health System
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 4 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a probiotic supplement can reduce relapse and improve outcomes for individuals hospitalized for bipolar depression. Participants will take either a probiotic capsule or a placebo daily for 24 weeks. The trial targets individuals recently admitted to a Sheppard Pratt program for bipolar disorder with a depressive episode. Those dealing with bipolar depression and who have had a recent hospital stay might find this trial suitable. As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important findings.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

Is there any evidence suggesting that the probiotic supplement is likely to be safe for humans?

Research has shown that probiotics, like those used in this trial, are generally safe and easy to tolerate. Studies have found that probiotic supplements can improve psychiatric symptoms and reduce the chances of rehospitalization in people with bipolar disorder, potentially offering benefits without serious side effects.

Participants who have taken probiotics before reported very few negative side effects. The specific probiotics in this trial, Lactobacillus rhamnosus LGG® and Bifidobacterium animalis subsp. lactis BB-12®, have been used in other studies and found to be safe for consumption.

Overall, evidence suggests that probiotics can be a safe option for people with bipolar disorder, although individual experiences may vary.12345

Why do researchers think this study treatment might be promising for bipolar disorder?

Most treatments for bipolar disorder involve mood stabilizers, antipsychotics, or antidepressants, which primarily target neurotransmitter imbalances. Unlike the standard of care, which often relies on these medications, the probiotic supplement uses live beneficial bacteria, specifically Lactobacillus rhamnosus LGG® and Bifidobacterium animalis subsp. lactis BB-12®. Researchers are excited about this treatment because it targets the gut-brain axis, a novel approach that may influence mental health by improving gut health. This innovative mechanism could offer a more natural alternative and potentially fewer side effects compared to traditional medications.

What evidence suggests that this probiotic supplement might be an effective treatment for bipolar disorder?

This trial will compare the effects of a Probiotic Supplement with an Inert Compound placebo in participants with bipolar disorder. Research suggests that probiotics might improve symptoms in people with bipolar disorder. Some studies have shown significant improvements in mental health symptoms with probiotic use. One study found that probiotics may reduce inflammation and enhance gut health, potentially benefiting mood disorders like bipolar disorder. Another study noted a slight improvement in cognitive skills for those taking probiotics. While not all studies have shown clear benefits, early results are promising for using probiotics to help manage bipolar disorder.12346

Who Is on the Research Team?

FD

Faith Dickerson, PhD, MPH

Principal Investigator

Sheppart Pratt Health System

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 who have been hospitalized for bipolar depression and can visit Sheppard Pratt Towson post-discharge. Participants must be fluent in English, able to consent, and diagnosed with Bipolar Disorder I or II. Exclusions include other mental disorders, substance abuse, significant medical conditions affecting the brain, pregnancy/breastfeeding women, recent investigational drug use or ECT treatment.

Inclusion Criteria

Proficient in the English language
I can understand and sign the consent form.
Available to come to Sheppard Pratt Towson for study visits after hospital discharge
See 1 more

Exclusion Criteria

Participated in any investigational drug trial in the 30 days prior to the Visit 1/Baseline visit
Pregnant, planning to become pregnant, or breastfeeding during the study period
I have not had electroconvulsive therapy in the last 30 days nor plan to after leaving the hospital.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either a probiotic supplement or placebo daily for 24 weeks

24 weeks
Regular visits for assessment at baseline, week 12, and week 24

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Inert Compound
  • Probiotic Supplement
Trial Overview The study aims to see if a probiotic supplement can prevent relapse in individuals recently hospitalized for bipolar depression compared to a placebo (an inert compound). The goal is to improve their clinical outcomes after discharge from the hospital.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Probiotic SupplementExperimental Treatment1 Intervention
Group II: Inert CompoundPlacebo Group1 Intervention

Probiotic Supplement is already approved in European Union, United States, Canada, Japan for the following indications:

🇪🇺
Approved in European Union as Probiotics for:
🇺🇸
Approved in United States as Probiotics for:
🇨🇦
Approved in Canada as Probiotics for:
🇯🇵
Approved in Japan as Probiotics for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Sheppard Pratt Health System

Lead Sponsor

Trials
23
Recruited
7,800+

Citations

Recent developments in the probiotics as live biotherapeutic ...The efficacy of probiotics for treatment of bipolar disorder-type 1: a randomized, double-blind, placebo controlled trial. Iran J Psychiatry ...
Probiotic Formulation for Patients With Bipolar or ...No significant effect of probiotics was observed on psychiatric symptoms, but borderline significant improvement was observed in the cognition ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37222849/
Probiotics, Live Biotherapeutic Products (LBPs), and Gut ...It is thought that LBPs may positively affect depression, anxiety, bipolar disorder, and schizophrenia by reducing inflammation, improving gut microbiota, and ...
Probiotic, prebiotic, synbiotic and fermented food ...In both studies the probiotic intervention was associated with a significant improvement in psychiatric symptoms and a significant improvement in ...
The Impact of Probiotic Supplements on Cognitive ...Conclusion: The results confirm the hypotheses that probiotic supplement might help stable individuals with BD to improve the cognitive function ...
Probiotics, Live Biotherapeutic Products (LBPs), and Gut ...This review focuses on the specific position of probiotics as LBPs in psychological conditions. Condition-specific potential pathways and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security